Cecchin E - Search Results

1

Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study.

van der Wouden CH, Böhringer S, Cecchin E, Cheung KC, Dávila-Fajardo CL, Deneer VHM, Dolžan V, Ingelman-Sundberg M, Jönsson S, Karlsson MO, Kriek M, Mitropoulou C, Patrinos GP, Pirmohamed M, Rial-Sebbag E, Samwald M, Schwab M, Steinberger D, Stingl J, Sunder-Plassmann G, Toffoli G, Turner RM, van Rhenen MH, van Zwet E, Swen JJ, Guchelaar HJ; Ubiquitous Pharmacogenomics Consortium. van der Wouden CH, et al. Among authors: cecchin e. Pharmacogenet Genomics. 2020 Aug;30(6):131-144. doi: 10.1097/FPC.0000000000000405. Pharmacogenet Genomics. 2020. PMID: 32317559 Free PMC article.

2

Pharmacogenetics of stomach cancer.

Toffoli G, Cecchin E. Toffoli G, et al. Among authors: cecchin e. Suppl Tumori. 2003 Sep-Oct;2(5):S19-22. Suppl Tumori. 2003. PMID: 12914384 Review.

3

UGT1A1*28 polymorphism in ovarian cancer patients.

Cecchin E, Russo A, Corona G, Campagnutta E, Martella L, Boiocchi M, Toffoli G. Cecchin E, et al. Oncol Rep. 2004 Aug;12(2):457-62. Oncol Rep. 2004. PMID: 15254716

4

Pharmacogenomics and stomach cancer.

Toffoli G, Cecchin E. Toffoli G, et al. Among authors: cecchin e. Pharmacogenomics. 2004 Sep;5(6):627-41. doi: 10.1517/14622416.5.6.627. Pharmacogenomics. 2004. PMID: 15335285 Review.

5

Carboxylesterase isoform 2 mRNA expression in peripheral blood mononuclear cells is a predictive marker of the irinotecan to SN38 activation step in colorectal cancer patients.

Cecchin E, Corona G, Masier S, Biason P, Cattarossi G, Frustaci S, Buonadonna A, Colussi A, Toffoli G. Cecchin E, et al. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6901-7. doi: 10.1158/1078-0432.CCR-05-0602. Clin Cancer Res. 2005. PMID: 16203781

6

Pharmacogenetics and stomach cancer: an update.

Toffoli G, Cecchin E. Toffoli G, et al. Among authors: cecchin e. Pharmacogenomics. 2007 May;8(5):497-505. doi: 10.2217/14622416.8.5.497. Pharmacogenomics. 2007. PMID: 17465714

7

Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan.

Cecchin E, Innocenti F, D'Andrea M, Corona G, De Mattia E, Biason P, Buonadonna A, Toffoli G. Cecchin E, et al. J Clin Oncol. 2009 May 20;27(15):2457-65. doi: 10.1200/JCO.2008.19.0314. Epub 2009 Apr 13. J Clin Oncol. 2009. PMID: 19364970

8

miRNA pharmacogenomics: the new frontier for personalized medicine in cancer?

Dreussi E, Biason P, Toffoli G, Cecchin E. Dreussi E, et al. Among authors: cecchin e. Pharmacogenomics. 2012 Nov;13(14):1635-50. doi: 10.2217/pgs.12.147. Pharmacogenomics. 2012. PMID: 23148639 Review.

9

Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment.

De Mattia E, Toffoli G, Polesel J, D'Andrea M, Corona G, Zagonel V, Buonadonna A, Dreussi E, Cecchin E. De Mattia E, et al. Among authors: cecchin e. Pharmacogenet Genomics. 2013 Oct;23(10):549-57. doi: 10.1097/FPC.0b013e328364b6cf. Pharmacogenet Genomics. 2013. PMID: 24018773

10

Pharmacogenetics of the nuclear hormone receptors: the missing link between environment and drug effects?

De Mattia E, Dreussi E, Cecchin E, Toffoli G. De Mattia E, et al. Among authors: cecchin e. Pharmacogenomics. 2013 Dec;14(16):2035-54. doi: 10.2217/pgs.13.214. Pharmacogenomics. 2013. PMID: 24279858 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

196 results

Search Page